✦ LIBER ✦

Comparative study of the pharmacokinetics and bioaccessibility of orthophen suppositories

✍ Scribed by E. V. Kompantseva; A. P. Kuznetsov; L. I. Karpenya; N. V. Blagorazumnaya; L. N. Dukkardt

Book ID: 106491439
Publisher: Springer
Year: 2005
Tongue: English
Weight: 80 KB
Volume: 39
Category: Article
ISSN: 0091-150X
DOI: 10.1007/s11094-006-0013-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative study of the pharmacokinetic

Comparative study of the pharmacokinetics and relative bioaccessibility of octidipine and nitrepine

✍ G. V. Ramenskaya; D. V. Reikhart; O. N. Astaev; A. K. Starodubtsev; V. G. Kukes 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 217 KB

A Comparative Study of the Pharmacokinet

A Comparative Study of the Pharmacokinetics and Bioaccessibility of Potassium Losartan in Various Medicinal Forms

✍ M. V. Gavrilin; S. A. Kuleshova 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 72 KB

Experimental study of pharmacokinetics a

Experimental study of pharmacokinetics and bioaccessibility of drug forms of pyricapyrone

✍ V. P. Zherdeev; I. V. Komissarov; T. A. Groshevoi; S. V. Naletov; G. B. Kolyvano 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 249 KB

Pharmacokinetics and bioaccessibility of

Pharmacokinetics and bioaccessibility of the tranquilizer phenazepam in dogs

✍ V. P. Zherdev; A. L. Ékonomov; L. M. Brestkina 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 385 KB

Comparative study of vitamin D2 and D3 p

Comparative study of vitamin D2 and D3 pharmacokinetics

✍ M. Seijo; S.R. Mastaglia; G.R. Brito; G.A. Keller; J. Somoza; R.A. Diez; G. DiGi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Comparative study of the pharmacokinetic

Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate

✍ A. Viala; B. Ba; A. Durand; F. Gouezo; Nhean Hou; A. Jørgensen 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 367 KB

Seventeen outpatients were treated with depot neuroleptics, zuclopenthixol decanoate in Viscoleo or flu-phena~e decanoate in sesame oil, with dosage intervals of 3 weeks. During the 4th, 6th, and 8th dosage interval blood samples were drawn in oxalated tubes. Plasma concentrations of the active neur